Viewing Study NCT00404768

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 5:36 PM
Ignite Modification Date: 2026-02-03 @ 5:25 AM
Study NCT ID: NCT00404768
Status: COMPLETED
Last Update Posted: 2018-01-16
First Post: 2006-11-27
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: The Safety, Tolerability And Metabolism Of GSK221149A, In Pregnant Women (30-36 Weeks), In Pre-Term Labor
Sponsor: GlaxoSmithKline
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Obstetric Labour, Premature View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Premature Labor View
None Pre Term Labor View
None intravenous View
None fetal fibronectin View